Pharmacokinetics of antibiotics in the lungs
- PMID: 2199210
Pharmacokinetics of antibiotics in the lungs
Abstract
This paper reviews current knowledge on the relationship between local penetration or antibiotics and therapeutic efficacy in pulmonary and bronchial infections. The antimicrobial drug concentration at the site of infection is supposedly determinative for the efficacy of the antibiotic treatment but the number of studies in respiratory infections supporting this hypothesis is limited. The mechanisms responsible for the pulmonary deposition or orally or systemically administered antibiotics include passive diffusion, active transport, bulk flow and permeation. The penetration of antimicrobial drugs into the respiratory tract is influenced by both host-related factors, such as inflammation or mechanical injury, and drug-related factors, such as molecular weight. In addition, local bio-inactivation can occur. The final bioactive antibiotic concentration at the site of the respiratory infection is, therefore, the result or a very complex dynamic process. Different sampling and measuring methods have been used for the assessment of antibiotic concentrations at the site of respiratory infections. Concentrations in sputum, bronchial secretions and biopsy specimens have been correlated with serum concentrations and clinical outcome. Bronchoalveolar lavage could be a promising technique for evaluating antibiotic drug concentrations in alveolar lining fluid. For many antibiotics, data concerning penetration and pharmacokinetic behaviour in the respiratory tract are lacking.
Similar articles
-
Antimicrobial drug concentrations and sampling techniques in the equine lung.Vet J. 2012 Aug;193(2):326-35. doi: 10.1016/j.tvjl.2012.02.010. Epub 2012 Mar 25. Vet J. 2012. PMID: 22449553 Review.
-
Delivering antibacterials to the lungs: considerations for optimizing outcomes.Am J Respir Med. 2002;1(4):261-72. doi: 10.1007/BF03256617. Am J Respir Med. 2002. PMID: 14720046 Review.
-
[Pharmacokinetic basis for antibiotic therapy in broncho-pulmonary bacterial infections (author's transl)].Rev Fr Mal Respir. 1982;10(3):195-203. Rev Fr Mal Respir. 1982. PMID: 7111829 French.
-
Predicting the efficacy of antimicrobial agents in respiratory infections--is tissue concentration a valid measure?J Antimicrob Chemother. 1995 Mar;35(3):363-71. doi: 10.1093/jac/35.3.363. J Antimicrob Chemother. 1995. PMID: 7782252 Review.
-
Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections.Clin Lab Med. 2004 Jun;24(2):477-502. doi: 10.1016/j.cll.2004.03.009. Clin Lab Med. 2004. PMID: 15177850 Review.
Cited by
-
Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients.Antimicrob Agents Chemother. 1992 Oct;36(10):2099-103. doi: 10.1128/AAC.36.10.2099. Antimicrob Agents Chemother. 1992. PMID: 1444291 Free PMC article.
-
Synchrotron-based X-ray fluorescence microscopy reveals accumulation of polymyxins in single human alveolar epithelial cells.Antimicrob Agents Chemother. 2023 May 1;65(5):e02314-20. doi: 10.1128/AAC.02314-20. Epub 2021 Mar 1. Antimicrob Agents Chemother. 2023. PMID: 33649114 Free PMC article.
-
Efficacy of aerosol MP-376, a levofloxacin inhalation solution, in models of mouse lung infection due to Pseudomonas aeruginosa.Antimicrob Agents Chemother. 2009 Sep;53(9):3923-8. doi: 10.1128/AAC.00268-09. Epub 2009 Jun 15. Antimicrob Agents Chemother. 2009. PMID: 19528273 Free PMC article.
-
Nebulized antibiotics in cystic fibrosis.Paediatr Drugs. 2002;4(7):455-67. doi: 10.2165/00128072-200204070-00004. Paediatr Drugs. 2002. PMID: 12083973 Review.
-
Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients.JAMA Pediatr. 2013 Oct;167(10):903-10. doi: 10.1001/jamapediatrics.2013.196. JAMA Pediatr. 2013. PMID: 23921724 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical